Respiratory complex II (CII, succinate dehydrogenase, SDH) inhibition can induce cell death, but the mechanistic details need clarification. To elucidate the role of reactive oxygen species (ROS) formation upon the ubiquinone-binding (Qp) site blockade, we substituted CII subunit C (SDHC) residues lining the Qp site by site-directed mutagenesis. Cell lines carrying these mutations were characterized on the bases of CII activity and exposed to Qp site inhibitors MitoVES, thenoyltrifluoroacetone (TTFA) and Atpenin A5. We found that I56F and S68A SDHC variants, which support succinate-mediated respiration and maintain low intracellular succinate, were less efficiently inhibited by MitoVES than the wild-type (WT) variant. Importantly, associated ROS generation and cell death induction was also impaired, and cell death in the WT cells was malonate and catalase sensitive. In contrast, the S68A variant was much more susceptible to TTFA inhibition than the I56F variant or the WT CII, which was again reflected by enhanced ROS formation and increased malonate- and catalase-sensitive cell death induction. The R72C variant that accumulates intracellular succinate due to compromised CII activity was resistant to MitoVES and TTFA treatment and did not increase ROS, even though TTFA efficiently generated ROS at low succinate in mitochondria isolated from R72C cells. Similarly, the high-affinity Qp site inhibitor Atpenin A5 rapidly increased intracellular succinate in WT cells but did not induce ROS or cell death, unlike MitoVES and TTFA that upregulated succinate only moderately. These results demonstrate that cell death initiation upon CII inhibition depends on ROS and that the extent of cell death correlates with the potency of inhibition at the Qp site unless intracellular succinate is high. In addition, this validates the Qp site of CII as a target for cell death induction with relevance to cancer therapy.

] Institute of Biotechnology Academy of Sciences of the Czech Republic Prague Czech Republic [2] School of Medical Science Griffith University Southport Queensland Australia

Faculty of Sciences Charles University Prague Czech Republic

Institute of Biotechnology Academy of Sciences of the Czech Republic Prague Czech Republic

Institute of Physiology Academy of Sciences of the Czech Republic Prague Czech Republic

School of Medical Science Griffith University Southport Queensland Australia

The Beatson Institute for Cancer Research Glasgow UK

Zobrazit více v PubMed

Cecchini G. Function and structure of complex II of the respiratory chain. Annu Rev Biochem 2003; 72: 77–109. PubMed

Maklashina E, Cecchini G. The quinone-binding and catalytic site of complex II. Biochim Biophys Acta 2010; 1797: 1877–1882. PubMed PMC

Sun F, Huo X, Zhai Y, Wang A, Xu J, Su D et al. Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 2005; 121: 1043–1057. PubMed

Iverson TM. Catalytic mechanisms of complex II enzymes: a structural perspective. Biochim Biophys Acta 2013; 1827: 648–657. PubMed PMC

Huang LS, Sun G, Cobessi D, Wang AC, Shen JT, Tung EY et al. 3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. J Biol Chem 2006; 281: 5965–5972. PubMed PMC

Quinlan CL, Orr AL, Perevoshchikova IV, Treberg JR, Ackrell BA, Brand MD. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J Biol Chem 2012; 287: 27255–27264. PubMed PMC

Siebels I, Drose S. Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates. Biochim Biophys Acta 2013; 1827: 1156–1164. PubMed

Moreno-Sanchez R, Hernandez-Esquivel L, Rivero-Segura NA, Marin-Hernandez A, Neuzil J, Ralph SJ et al. Reactive oxygen species are generated by the respiratory complex II—evidence for lack of contribution of the reverse electron flow in complex I. FEBS J 2013; 280: 927–938. PubMed

Messner KR, Imlay JA. Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase. J Biol Chem 2002; 277: 42563–42571. PubMed

Zhang L, Yu L, Yu CA. Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J Biol Chem 1998; 273: 33972–33976. PubMed

Kluckova K, Bezawork-Geleta A, Rohlena J, Dong L, Neuzil J. Mitochondrial complex II, a novel target for anti-cancer agents. Biochim Biophys Acta 2013; 1827: 552–564. PubMed

Grimm S. Respiratory chain complex II as general sensor for apoptosis. Biochim Biophys Acta 2013; 1827: 565–572. PubMed

Hwang MS, Schwall CT, Pazarentzos E, Datler C, Alder NN, Grimm S. Mitochondrial Ca influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction. Cell Death Differ 2014; 21: 1733–1745. PubMed PMC

Lemarie A, Huc L, Pazarentzos E, Mahul-Mellier AL, Grimm S. Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction. Cell Death Differ 2011; 18: 338–349. PubMed PMC

Hwang MS, Rohlena J, Dong LF, Neuzil J, Grimm S. Powerhouse down: complex II dissociation in the respiratory chain. Mitochondrion 2014; 19(Pt A): 20–28. PubMed

Dong LF, Jameson VJ, Tilly D, Cerny J, Mahdavian E, Marin-Hernandez A et al. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II. J Biol Chem 2011; 286: 3717–3728. PubMed PMC

Dong LF, Jameson VJ, Tilly D, Prochazka L, Rohlena J, Valis K et al. Mitochondrial targeting of alpha-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy. Free Radic Biol Med 2011; 50: 1546–1555. PubMed

Rohlena J, Dong LF, Kluckova K, Zobalova R, Goodwin J, Tilly D et al. Mitochondrially targeted alpha-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing. Antioxid Redox Signal 2011; 15: 2923–2935. PubMed PMC

Rodriguez-Enriquez S, Hernandez-Esquivel L, Marin-Hernandez A, Dong LF, Akporiaye ET, Neuzil J et al. Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue. Biochim Biophys Acta 2012; 1817: 1597–1607. PubMed

Neuzil J, Dong LF, Rohlena J, Truksa J, Ralph SJ. Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion 2013; 13: 199–208. PubMed

Szeto SS, Reinke SN, Sykes BD, Lemire BD. Ubiquinone-binding site mutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate. J Biol Chem 2007; 282: 27518–27526. PubMed

Tran QM, Rothery RA, Maklashina E, Cecchini G, Weiner JH. The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b. J Biol Chem 2006; 281: 32310–32317. PubMed

Yang X, Yu L, He D, Yu CA. The Quinone-binding Site in Succinate-ubiquinone Reductase fromEscherichia coli: quinone-binding domain and amino acid residues involved in quinone binding. J Biol Chem 1998 1998; 273: 31916–31923. PubMed

Horsefield R, Yankovskaya V, Sexton G, Whittingham W, Shiomi K, Omura S et al. Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction. J Biol Chem 2006; 281: 7309–7316. PubMed

Oostveen FG, Au HC, Meijer PJ, Scheffler IE. A Chinese hamster mutant cell line with a defect in the integral membrane protein CII-3 of complex II of the mitochondrial electron transport chain. J Biol Chem 1995; 270: 26104–26108. PubMed

Pesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 2012; 810: 25–58. PubMed

Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005; 7: 77–85. PubMed

Yanamala N, Kapralov AA, Djukic M, Peterson J, Mao G, Klein-Seetharaman J et al. Structural re-arrangement and peroxidase activation of cytochrome c by anionic analogues of vitamin E, tocopherol succinate and tocopherol phosphate. J Biol Chem 2014; 289: 32488–32498. PubMed PMC

Rauchova H, Vokurkova M, Drahota Z. Inhibition of mitochondrial glycerol-3-phosphate dehydrogenase by alpha-tocopheryl succinate. Int J Biochem Cell Biol 2014; 53: 409–413. PubMed

Miyadera H, Shiomi K, Ui H, Yamaguchi Y, Masuma R, Tomoda H et al. Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase). Proc Natl Acad Sci U S A 2003; 100: 473–477. PubMed PMC

Kearney EB, Ackrell BA, Mayr M. Tightly bound oxalacetate and the activation of succinate dehydrogenase. Biochem Biophys Res Commun 1972; 49: 1115–1121. PubMed

Muller FL, Liu Y, Abdul-Ghani MA, Lustgarten MS, Bhattacharya A, Jang YC et al. High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I- and complex II-linked substrates. Biochem J 2008; 409: 491–499. PubMed

Lemarie A, Grimm S. Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer? Oncogene 2011; 30: 3985–4003. PubMed

Ricci JE, Gottlieb RA, Green DR. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol 2003; 160: 65–75. PubMed PMC

Kwong JQ, Henning MS, Starkov AA, Manfredi G. The mitochondrial respiratory chain is a modulator of apoptosis. J Cell Biol 2007; 179: 1163–1177. PubMed PMC

Dong LF, Freeman R, Liu J, Zobalova R, Marin-Hernandez A, Stantic M et al. Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res 2009; 15: 1593–1600. PubMed

Dong LF, Low P, Dyason JC, Wang XF, Prochazka L, Witting PK et al. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008; 27: 4324–4335. PubMed PMC

Drose S. Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning. Biochim Biophys Acta 2013; 1827: 578–587. PubMed

Mbaya E, Oules B, Caspersen C, Tacine R, Massinet H, Pennuto M et al. Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency. Cell Death Differ 2010; 17: 1855–1866. PubMed

Choi WS, Palmiter RD, Xia Z. Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model. J Cell Biol 2011; 192: 873–882. PubMed PMC

Ren Y, Feng J. Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism. J Neurochem 2007; 103: 303–311. PubMed

Tzung SP, Kim KM, Basanez G, Giedt CD, Simon J, Zimmerberg J et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol 2001; 3: 183–191. PubMed

Shiau CW, Huang JW, Wang DS, Weng JR, Yang CC, Lin CH et al. alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function. J Biol Chem 2006; 281: 11819–11825. PubMed

Rohlena J, Dong LF, Ralph SJ, Neuzil J. Anticancer drugs targeting the mitochondrial electron transport chain. Antioxid Redox Signal 2011; 15: 2951–2974. PubMed

Mracek T, Jesina P, Krivakova P, Bolehovska R, Cervinkova Z, Drahota Z et al. Time-course of hormonal induction of mitochondrial glycerophosphate dehydrogenase biogenesis in rat liver. Biochim Biophys Acta 2005; 1726: 217–223. PubMed

Schmitt S, Saathoff F, Meissner L, Schropp EM, Lichtmannegger J, Schulz S et al. A semi-automated method for isolating functionally intact mitochondria from cultured cells and tissue biopsies. Anal Biochem 2013; 443: 66–74. PubMed

Wittig I, Karas M, Schagger H. High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complexes. Mol Cell Proteomics 2007; 6: 1215–1225. PubMed

Truksa J, Dong LF, Rohlena J, Stursa J, Vondrusova M, Goodwin J et al. Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis. Antioxid Redox Signal 2015; 22: 883–900. PubMed

Hroudova J, Fisar Z. In vitro inhibition of mitochondrial respiratory rate by antidepressants. Toxicol Lett 2012; 213: 345–352. PubMed

Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 1997; 253: 162–168. PubMed

Lortz S, Gurgul-Convey E, Naujok O, Lenzen S. Overexpression of the antioxidant enzyme catalase does not interfere with the glucose responsiveness of insulin-secreting INS-1E cells and rat islets. Diabetologia 2013; 56: 774–782. PubMed

Webb B, Sali A. Protein Structure Modeling with MODELLER. Protein Structure Prediction, 3rd Edition 2014; 1137: 1–15. PubMed

Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res 2005; 33: W382–W388. PubMed PMC

Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008; 4: 435–447. PubMed

Eastman P, Friedrichs MS, Chodera JD, Radmer RJ, Bruns CM, Ku JP et al. OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation. J Chem Theory Comput 2013; 9: 461–469. PubMed PMC

Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785–2791. PubMed PMC

Sanner MF. Python: a programming language for software integration and development. J Mol Graph Model 1999; 17: 57–61. PubMed

Mitochondrial complex II and reactive oxygen species in disease and therapy

Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2

Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints

Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production

Mitochondrial Complex II: At the Crossroads

Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells

Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2high Breast Cancer

The Assembly Factor SDHAF2 Is Dispensable for Flavination of the Catalytic Subunit of Mitochondrial Complex II in Breast Cancer Cells

Impaired mitochondrial functions contribute to 3-bromopyruvate toxicity in primary rat and mouse hepatocytes